Stock listing
Xetra:1VT Viking Therapeutics, Inc. Aktie
German listing (Xetra) of Viking Therapeutics, Inc. · home listing NASDAQ:VKTX
Follow Viking Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:VKTX
$26.83 USD -0.45 (-1.6%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:VKTX
- Day range
- $26.55 – $27.89 USDNov 2, 2026
- Volume
- 4.43M sharesNov 2, 2026
- Market cap
- $3.41B USDAt the close on Nov 2, 2026 · price × 127.2M shares outstanding
- 52-week range
- $23.82 – $43.15 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $155.7M USDMedian day 2.86M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VKTX · Home | $26.83 USD | -0.45 (-1.6%) | 4,426,554 | $27.25 | $27.89 | $26.55 | $27.28 | Close on Nov 2, 2026 |
| Frankfurt:1VT | €24.15 EUR | +2.80 (+13.1%) | — | €23.30 | €24.15 | €23.30 | €21.35 | Close on Oct 30, 2026 |
| LSE:0VQA | $24.89 USD | +0.39 (+1.6%) | 14,624 | $24.11 | $24.90 | $23.93 | $24.50 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:VKTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $26.83 | -0.45 | -1.6% | $27.25 | $27.89 | $26.55 | 4,426,554 | |
| $27.28 | +0.42 | +1.6% | $26.69 | $27.83 | $26.31 | 5,085,875 | |
| $26.86 | +1.50 | +5.9% | $24.38 | $27.72 | $24.38 | 6,741,133 | |
| $25.36 | +0.47 | +1.9% | $24.69 | $25.41 | $24.42 | 4,146,895 | |
| $24.89 | +0.68 | +2.8% | $24.23 | $24.93 | $23.82 | 3,304,758 | |
| $24.21 | -0.19 | -0.8% | $24.35 | $24.90 | $24.01 | 3,511,056 | |
| $24.40 | -1.43 | -5.5% | $25.54 | $25.74 | $24.36 | 4,660,600 | |
| $25.83 | -0.55 | -2.1% | $26.36 | $26.79 | $25.66 | 3,525,000 | |
| $26.38 | -0.33 | -1.2% | $26.83 | $27.29 | $26.31 | 3,293,400 | |
| $26.71 | +1.66 | +6.6% | $25.10 | $26.92 | $25.00 | 4,649,700 | |
| $25.05 | -0.12 | -0.5% | $25.40 | $25.81 | $25.02 | 3,741,100 | |
| $25.17 | -2.20 | -8.0% | $27.17 | $27.35 | $24.94 | 7,582,100 | |
| $27.37 | +1.90 | +7.5% | $26.10 | $27.51 | $25.86 | 5,215,600 | |
| $25.47 | -1.18 | -4.4% | $26.50 | $26.89 | $25.28 | 6,581,100 | |
| $26.65 | -1.69 | -6.0% | $28.20 | $28.20 | $26.60 | 5,739,200 | |
| $28.34 | -0.17 | -0.6% | $28.23 | $28.84 | $27.91 | 2,861,900 | |
| $28.51 | +0.78 | +2.8% | $27.85 | $28.86 | $27.58 | 4,036,200 | |
| $27.73 | -0.81 | -2.8% | $28.37 | $28.49 | $27.05 | 8,732,700 | |
| $28.54 | +0.16 | +0.6% | $28.39 | $29.06 | $28.12 | 5,401,700 | |
| $28.38 | -0.90 | -3.1% | $29.49 | $29.72 | $28.17 | 7,109,600 | |
| $29.28 | -0.66 | -2.2% | $30.14 | $30.18 | $28.71 | 6,277,400 | |
| $29.94 | -0.57 | -1.9% | $30.85 | $31.09 | $29.90 | 6,367,100 | |
| $30.51 | -2.09 | -6.4% | $31.92 | $32.48 | $30.43 | 6,832,000 | |
| $32.60 | +0.79 | +2.5% | $31.86 | $33.29 | $31.20 | 7,000,100 | |
| $31.81 | -1.22 | -3.7% | $33.11 | $33.65 | $31.42 | 8,025,800 | |
| $33.03 | -2.53 | -7.1% | $35.00 | $35.19 | $32.91 | 8,575,400 | |
| $35.56 | -1.19 | -3.2% | $37.80 | $39.05 | $35.10 | 13,579,200 | |
| $36.75 | -4.90 | -11.8% | $36.03 | $37.22 | $35.11 | 28,707,300 | |
| $41.65 | +0.80 | +2.0% | $41.76 | $43.10 | $37.71 | 15,732,200 | |
| $40.85 | +10.74 | +35.7% | $37.00 | $41.73 | $36.34 | 41,227,600 | |
| $30.11 | +1.12 | +3.9% | $29.57 | $30.70 | $28.41 | 5,086,700 | |
| $28.99 | -0.37 | -1.3% | $29.57 | $29.68 | $28.40 | 2,665,300 | |
| $29.36 | -0.16 | -0.5% | $30.24 | $30.54 | $29.26 | 2,085,500 | |
| $29.52 | -0.43 | -1.4% | $30.02 | $30.77 | $28.80 | 3,003,200 | |
| $29.95 | -1.58 | -5.0% | $31.21 | $31.25 | $29.70 | 2,805,100 | |
| $31.53 | -0.45 | -1.4% | $31.70 | $32.43 | $31.39 | 1,842,900 | |
| $31.98 | -0.15 | -0.5% | $32.26 | $33.05 | $31.70 | 2,204,900 | |
| $32.13 | -0.57 | -1.7% | $32.50 | $32.65 | $31.87 | 1,711,000 | |
| $32.70 | -0.98 | -2.9% | $33.36 | $34.60 | $32.59 | 2,032,000 | |
| $33.68 | -1.19 | -3.4% | $34.63 | $34.81 | $33.53 | 1,865,100 | |
| $34.87 | +0.89 | +2.6% | $33.75 | $34.95 | $33.56 | 1,400,800 | |
| $33.98 | +0.48 | +1.4% | $34.00 | $34.45 | $33.68 | 1,394,100 | |
| $33.50 | -0.17 | -0.5% | $33.67 | $34.75 | $32.77 | 1,572,600 | |
| $33.67 | +0.89 | +2.7% | $32.61 | $33.71 | $32.38 | 1,675,100 | |
| $32.78 | +0.62 | +1.9% | $31.77 | $32.98 | $31.70 | 1,779,900 | |
| $32.16 | -1.70 | -5.0% | $33.75 | $33.86 | $31.98 | 2,375,700 | |
| $33.86 | -0.52 | -1.5% | $34.33 | $34.39 | $33.15 | 2,205,900 | |
| $34.38 | +0.21 | +0.6% | $34.09 | $34.75 | $33.80 | 1,142,900 | |
| $34.17 | +0.94 | +2.8% | $33.67 | $34.99 | $33.43 | 2,095,500 | |
| $33.23 | -0.66 | -1.9% | $33.75 | $33.77 | $32.61 | 1,745,800 | |
| $33.89 | -0.47 | -1.4% | $34.79 | $34.98 | $33.47 | 1,501,100 | |
| $34.36 | -1.62 | -4.5% | $35.79 | $35.79 | $33.96 | 1,670,700 | |
| $35.98 | +2.61 | +7.8% | $34.10 | $36.26 | $33.83 | 2,686,200 | |
| $33.37 | -0.26 | -0.8% | $33.42 | $33.94 | $33.00 | 1,194,100 | |
| $33.63 | +0.44 | +1.3% | $33.13 | $33.83 | $32.76 | 1,526,100 | |
| $33.19 | +0.25 | +0.8% | $32.56 | $33.28 | $32.34 | 1,180,600 | |
| $32.94 | -1.08 | -3.2% | $33.86 | $33.97 | $32.53 | 3,706,900 | |
| $34.02 | +0.22 | +0.7% | $34.07 | $34.74 | $33.50 | 1,473,700 | |
| $33.80 | -0.64 | -1.9% | $34.71 | $34.85 | $33.62 | 1,011,700 | |
| $34.44 | +0.18 | +0.5% | $33.93 | $34.70 | $33.80 | 1,617,600 | |
| $34.26 | +0.96 | +2.9% | $33.82 | $34.33 | $33.21 | 1,402,500 | |
| $33.30 | -0.21 | -0.6% | $33.50 | $34.20 | $33.10 | 1,302,900 | |
| $33.51 | +0.57 | +1.7% | $33.19 | $34.08 | $32.96 | 1,960,700 | |
| $32.94 | +0.33 | +1.0% | $32.95 | $33.62 | $32.58 | 1,701,800 | |
| $32.61 | +0.87 | +2.7% | $31.68 | $32.73 | $31.28 | 1,598,800 |
- Ticker
- Xetra:1VT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Xetra
- Currency
- EUR
What changed lately
Latest news release · Oct 28, 2026
Viking Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Latest earnings call · Oct 28, 2026
Viking Therapeutics (NASDAQ:VKTX) Q3 2026 Earnings Call
Replay and transcript
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 51 slides
Calls
Replays
Viking Therapeutics (NASDAQ:VKTX) Q3 2026 Earnings Call
Wed, Oct 28, 2026 · 4:30 PM ET
Watch TranscriptViking Therapeutics (NASDAQ:VKTX) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 4:30 PM ET
Watch TranscriptViking Therapeutics (NASDAQ:VKTX) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Viking Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Oct 28, 2026
Closed $26.86 (+5.9%) on Oct 29, 2026
Viking Therapeutics to Report Financial Results for Third Quarter 2026 on October 28, 2026
Oct 21, 2026
Closed $25.83 (-2.1%) on Oct 22, 2026
Viking Therapeutics Announces Initiation of VK2735 Oral Phase 3 Clinical Program in Patients with Obesity
Oct 14, 2026
Closed $25.47 (-4.4%) on Oct 14, 2026
Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity
Oct 6, 2026
Closed $28.38 (-3.1%) on Oct 6, 2026
Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Common Stock and Convertible Senior Notes
Sep 28, 2026
Closed $31.81 (-3.7%) on Sep 29, 2026
Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes
Sep 23, 2026
Closed $36.75 (-11.8%) on Sep 24, 2026
Viking Therapeutics Announces Positive Topline Results from Maintenance Study of GLP-1/GIP Agonist VK2735 Demonstrating the Promise of Multiple Maintenance Dosing Regimens
Sep 22, 2026
Closed $40.85 (+35.7%) on Sep 22, 2026
Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Jul 29, 2026
Closed $33.11 (-1.0%) on Jul 30, 2026
Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors
Jul 23, 2026
Closed $35.39 (-5.1%) on Jul 23, 2026
Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026
Jul 22, 2026
Closed $35.39 (-5.1%) on Jul 23, 2026
Financings
Public offering of common stock
Sep 28, 2026
Closed: US$200M raised · US$35 a share · Morgan Stanley & Co. LLC +12
Dealers: Morgan Stanley & Co. LLC (co-lead), J.P. Morgan Securities LLC (co-lead), J.P. Morgan (co-lead), Jefferies (co-lead), Leerink Partners (co-lead), William Blair (co-lead), Raymond James (co-lead), Oppenheimer & Co., Canaccord Genuity, H.C. Wainwright & Co., B. Riley Securities, Maxim Group LLC, Laidlaw & Company (U.K.) Ltd.
Use of proceeds: Clinical development and commercialization of VK2735, development of VK3019, other R&D, working capital and general corporate purposes
2.00% convertible senior notes due 2032
Sep 28, 2026
Closed: US$258.75M raised · Morgan Stanley & Co. LLC +5
Dealers: Morgan Stanley & Co. LLC (co-lead), J.P. Morgan Securities LLC (co-lead), J.P. Morgan (co-lead), Jefferies (co-lead), Leerink Partners (co-lead), William Blair (co-lead)
Use of proceeds: Clinical development and commercialization of VK2735, development of VK3019, other R&D, working capital and general corporate purposes
Decks
Investor Presentation (October 2026)
Investor deck · 51 slides · October 2026
Investor Presentation (October 2026)
Investor deck · 51 slides · October 2026
Technical Presentation (September 2026)
Technical · 14 slides · September 2026
Investor Presentation (August 2026)
Investor deck · 35 slides · August 2026
Viking Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 148 in all · newest Oct 28, 2026 · oldest 2019
- Calls
- 19 calls with a replay · 19 with a transcript · latest Oct 28, 2026
- Decks
- 6 decks · latest October 2026
Where Viking Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VKTX · Home listing | NASDAQ | United States | USD |
| gettex:1VT | gettex | Germany | EUR |
| LS Exchange:A12GD6 | LS Exchange | Germany | EUR |
| Tradegate:1VT | Tradegate | Germany | EUR |
| Frankfurt:1VT | Frankfurt | Germany | EUR |
| BX Swiss:VKTX | BX Swiss | Switzerland | CHF |
| Lang & Schwarz:A12GD6 | Lang & Schwarz | Germany | EUR |
| Milan:1VKTX | Milan | Italy | EUR |
| LSE:0VQA | LSE | United Kingdom | USD |
| BOATS:VKTX | BOATS | United States | USD |
| Stuttgart:1VT | Stuttgart | Germany | EUR |
| Dusseldorf:1VT | Dusseldorf | Germany | EUR |
| Hamburg:1VT | Hamburg | Germany | EUR |
| Munich:1VT | Munich | Germany | EUR |
| Hanover:1VT | Hanover | Germany | EUR |
| Xetra:1VT · This page | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Viking Therapeutics, Inc.